Searched for
BIOCON BENGALURU PLANT
Biocon inaugurates first manufacturing facility in USBiocon Ltd has inaugurated its first US manufacturing facility in Cranbury, New Jersey, operated by its subsidiary, Biocon Generics Inc. Fo...
Biocon shares zoom 4% as Jefferies upgrades to "hold" amid positive news inflow, sets Rs 400 targetBiocon share price: This upgrade reflects a more positive outlook on the company following recent favorable news flow, particularly concern...
Stocks to buy today: CLSA upgrades ONGC; Citi initiates buy on Hyundai Motor IndiaCLSA has upgraded ONGC to "High Conviction Overweight-PF," citing multiple production and realization triggers, alongside attractive valuat...
Biocon shares surge 5% after USFDA classifies Bengaluru site as VAIBiocon Share Price: Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is...
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plantBiocon Biologics received EMA approval to manufacture biosimilar Bevacizumab in Bengaluru, providing additional capacity to address patient...
Biocon acquires Eywa Pharma's US-based plant for $7.7 millionBiocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.’s oral solid dosage manufact...
Biocon's growth drivers are in place: 5 reasons it is this week's stock pickImproving prospects of the pharma industry, growth in the global generics market, expanded product portfolio and cost reduction initiatives...
Biocon drops 4% as USFDA issues form 483 for 3 sitesAs per the US Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at the conclusion of an inspection when an in...
Biocon Biologics receives observations from USFDA: BioconThe USFDA conducted three on-site inspections of Biocon Biologics' seven manufacturing facilities spanning two sites in Bengaluru, India an...
Biocon Biologics gets EU GMP certification from Ireland's HPRAThe company's new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru has received the certif...
Biocon gets establishment inspection report from USFDA for Bengaluru plantThe EIR has been closed with a voluntary action indicated (VAI) classification for the observations, it added. As per the USFDA, a VAI mean...
Market Movers: NTPC, ICICI Bank, SBI, Motherson jump; 32 stocks ‘overbought'Banks were among the top drivers of the rally, with ICICI Bank rallying 5% and SBI 3.5%.
USFDA clears four Indian manufacturing plants in 10 daysIndia’s leading drug companies have had their manufacturing facilities cleared in the last 10 days by the US Food and Drug Administration (...
Biocon gets 6 observations from USFDA after inspection of its Bengaluru plantBiocon is confident of addressing these expeditiously and remains committed to global standards of quality and compliance, the statement ad...
Biocon's insulin facility in Malaysia clears inspections for European marketThe facility, set up with an investment of $275 million, is designed to manufacture recombinant human insulin and insulin analogs for the g...
Biocon's pain could continue post EU drug application withdrawalBiocon shares tanked 5.9 per cent to Rs 328.80 at the close on the BSE on Wednesday.
Biocon shares drop after French regulator finds lapses at its plantANSM has raised deficiencies concerning two biosimilar products intended in the treatment of cancer and one intended for diabetes.
Industrial enzymes leader Novozymes to expand India operationsSpeaking to ET, GS Krishnan, Regional President, Novozymes India said among other things, the new site is expected to help meet requirement...
Industry leaders converge in Bengaluru for Invest Karnataka 2016At the event, Sajjan Jindal, the managing director of JSW Steel announced a Rs 35,000 crore investment in the state.
Parliament-like battle on Twitter over Land Acquisition BillShaw was immediately perceived as the face of corporate India and the Congress trolls swung into action, painting her stand as anti-farmer.